Berliner Boersenzeitung - US vaccine panel upends hepatitis B advice in latest Trump-era shift

EUR -
AED 4.244615
AFN 76.271918
ALL 93.366197
AMD 423.127183
AOA 1059.724062
ARS 1729.175777
AUD 1.636562
AWG 2.083045
AZN 1.957641
BAM 1.957599
BBD 2.326338
BDT 142.971375
BHD 0.43579
BIF 3458.258419
BMD 1.155642
BND 1.481061
BOB 14.027586
BRL 5.93827
BSD 1.155061
BTN 109.807426
BWP 15.663325
BYN 3.416139
BYR 22650.58146
BZD 2.322984
CAD 1.618806
CDF 2612.906548
CHF 0.932447
CLF 0.026736
CLP 1055.7021
CNY 7.800486
CNH 7.79785
COP 3677.241005
CRC 523.781299
CUC 1.155642
CUP 30.624511
CVE 110.59024
CZK 24.186025
DJF 205.38031
DKK 7.475767
DOP 67.315816
DZD 153.48698
EGP 57.552815
ERN 17.334629
ETB 186.42297
FJD 2.553387
FKP 0.8589
GBP 0.857966
GEL 3.016319
GGP 0.8589
GHS 13.549949
GIP 0.8589
GMD 84.931373
GNF 10149.421488
GTQ 8.810096
GYD 241.612608
HKD 9.064618
HNL 30.958447
HRK 7.535247
HTG 151.01877
HUF 361.674896
IDR 20654.036712
ILS 3.47126
IMP 0.8589
INR 109.880802
IQD 1513.090368
IRR 1588776.499747
ISK 141.785837
JEP 0.8589
JMD 183.548662
JOD 0.819314
JPY 182.194461
KES 149.505174
KGS 101.061253
KHR 4681.281342
KMF 494.614915
KRW 1642.617952
KWD 0.357348
KYD 0.96258
KZT 542.015709
LAK 26109.426943
LBP 103430.10369
LKR 387.596159
LRD 208.480669
LSL 18.948812
LTL 3.412309
LVL 0.699036
LYD 7.351755
MAD 10.765192
MDL 20.068354
MGA 4916.411299
MKD 61.586591
MMK 2426.04177
MNT 4158.228086
MOP 9.331434
MRU 46.31656
MUR 54.303823
MVR 17.866105
MWK 2002.762338
MXN 19.920816
MYR 4.731317
MZN 73.845071
NAD 18.948812
NGN 1573.810703
NIO 42.509061
NOK 10.997146
NPR 175.693203
NZD 1.961696
OMR 0.444347
PAB 1.155036
PEN 3.909993
PGK 5.178759
PHP 70.091418
PKR 320.721208
PLN 4.300372
PYG 6888.329638
QAR 4.22278
RON 5.246149
RSD 117.338123
RUB 93.584616
RWF 1696.751792
SAR 4.33658
SBD 9.327822
SCR 15.500574
SDG 693.961358
SEK 10.955543
SGD 1.480296
SLE 27.6199
SOS 660.109426
SRD 43.530693
STD 23919.45433
STN 24.522534
SVC 10.106287
SZL 18.93348
THB 38.24539
TJS 10.660665
TMT 4.056303
TND 3.389114
TRY 54.972156
TTD 7.8352
TWD 37.31753
TZS 3062.448769
UAH 51.687796
UGX 4307.958553
USD 1.155642
UYU 46.442676
UZS 13730.616967
VES 871.59813
VND 30336.755811
VUV 138.173179
WST 3.162706
XAF 656.557465
XAG 0.018588
XAU 0.000272
XCD 3.12318
XCG 2.081622
XDR 0.817563
XOF 655.82124
XPF 119.331742
YER 275.44734
ZAR 18.845636
ZMK 10402.165875
ZMW 22.048783
ZWL 372.116224
  • CMSC

    -0.0100

    21.78

    -0.05%

  • BCC

    -1.6600

    84.83

    -1.96%

  • RIO

    2.4700

    101.48

    +2.43%

  • NGG

    -0.3000

    80.12

    -0.37%

  • GSK

    -0.0850

    51.445

    -0.17%

  • CMSD

    -0.0600

    21.96

    -0.27%

  • BTI

    0.2250

    59.345

    +0.38%

  • AZN

    5.9700

    161.59

    +3.69%

  • BP

    -0.7200

    41.72

    -1.73%

  • RBGPF

    -1.2500

    69.74

    -1.79%

  • JRI

    -0.0350

    12.685

    -0.28%

  • RYCEF

    0.6500

    21

    +3.1%

  • BCE

    -0.1850

    21.815

    -0.85%

  • RELX

    -0.2300

    36.57

    -0.63%

  • VOD

    -0.3650

    15.325

    -2.38%

US vaccine panel upends hepatitis B advice in latest Trump-era shift
US vaccine panel upends hepatitis B advice in latest Trump-era shift / Photo: ANDREW CABALLERO-REYNOLDS - AFP

US vaccine panel upends hepatitis B advice in latest Trump-era shift

An advisory panel appointed by the Trump administration's vaccine-skeptic health secretary voted Friday to stop recommending that all newborns in the United States receive a hepatitis B vaccine.

Text size:

The move to end the decades-old recommendation is the panel's latest contentious about-face on vaccine policy since its overhaul by Health Secretary Robert F. Kennedy Jr. earlier this year.

US health authorities previously recommended all babies, not just those born to mothers believed to have hepatitis B, receive the first of three vaccine doses just after birth.

The approach aimed, in part, to prevent transfers from mothers who unknowingly had hepatitis B or had falsely tested negative, and had virtually eradicated infections of the potentially deadly liver disease among young people in the country.

After delaying the vote by a day, the panel on Friday passed its new recommendation for "individual-based decision-making," in consultation with a health care provider, when children are born to mothers testing negatively for the disease.

The decision to vaccinate at birth should "consider vaccine benefits, vaccine risks, and infection risks."

The new recommendation was immediately condemned by several medical groups who noted widespread shortcomings in US maternal health screening as well as the possibility of infections from others.

"This irresponsible and purposely misleading guidance will lead to more hepatitis B infections in infants and children," American Academy of Pediatrics President Susan J. Kressly said in a statement.

The vote was 8-3. Trump-appointed officials at the Centers for Disease Control and Prevention (CDC) are expected to formally adopt the recommendations at a later date.

The panel also voted to recommend that babies who are not vaccinated at birth wait at least two months to get the initial dose, and that blood tests be done to measure antibodies before a second dose.

- Panel overhaul -

After becoming health secretary, Kennedy sacked every member of the once-staid Advisory Committee on Immunization Practices (ACIP), replacing them with figures whose vaccine-skeptic views track more closely with his own.

It has since set to work on reviewing prior recommendations -- already tweaking advice on Covid-19 and measles shots.

Medical experts fear the push could further contribute to declining vaccination rates in the United States.

The panel on Friday also began a broader review of the childhood vaccination schedule, and sparked further controversy by allowing testimony from lawyer Aaron Siri, a close Kennedy associate known for spreading unfounded theories on the subject.

While US President Donald Trump vocally supports Kennedy's policies, some in the Republican Party have pushed back, notably Louisiana Senator Bill Cassidy.

Medical doctor Cassidy condemned the ACIP decision on Friday, noting the original recommendation was never "a mandate" to get the jab.

CDC officials "should not sign these new recommendations and instead retain the current, evidence-based approach," he said on X.

Cassidy's expression of alarm, like his prior statements against Kennedy, provoked criticism after he provided the key vote to confirm the health secretary in February.

- 'Do no harm' -

The United States had urged universal vaccination at birth against hepatitis B since 1991, advice also recommended by China, Australia and the World Health Organization.

But several ACIP members argued Friday's decision would align the United States with other economically developed countries such as France and Britain.

The repercussions of the ACIP's vaccine recommendations are broad because federal guidelines often dictate whether vaccines are paid for by health insurance companies in the United States, where a vaccine can cost hundreds of dollars.

But the committee's influence is waning amid withering criticism from the US scientific and medical community, with Democratic-led states announcing they will no longer follow its recommendations.

Ahead of the vote, Dr. Cody Meissner, one of the few dissenting voices on the advisory committee, urged his colleagues not to change the current recommendations.

"Do no harm is a moral imperative. We are doing harm by changing this wording," he warned.

(Y.Berger--BBZ)